| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |